Hyperthyroidism after radiofrequency ablation for thyroid nodule
The Kaohsiung Journal of Medical Sciences · 2024
DOI: 10.1002/kjm2.12809 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2024. Verfasst von How-Chen Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Thyroid Nodule, Radiofrequency Ablation, Hyperthyroidism, Catheter Ablation. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaohsiung Medical University Hospital, Kaohsiung Medical University, National Science and Technology Council, Taiwan, Kaohsiung Medical University Hospital.
Abstract (Originalsprache)
Radiofrequency ablation (RFA) is a novel treatment for selected thyroid nodules and is known for its low complication rate when performed precisely.1,2 Hyperthyroidism typically occurs within 2-4 weeks post-RFA, is transient and self-limiting and is hypothesized to be caused by destructive thyroiditis. 1 We present a case of hyperthyroidism that developed 3 months post-RFA.A 41-year-old Taiwanese woman presented with a movable midline neck mass and mild compressive symptoms without tenderness or thyrotoxic signs.She smoked a pack daily and denied past irradiation, a history of thyroid disease, or any significant family history.Thyroid sonography revealed a low-risk 3.20 Â 2.62 Â 3.63 cm left thyroid nodule with peripheral vascularity (Figure 1A) and an unremarkable right lobe.Two fine-needle aspirations showed a benign cytology.Her serum-free T4, thyroglobulin (Tg), and Tg antibody levels were normal, in contrast with her low TSH and high microsomal Ab levels.After shared decision-making and informed consent, the patient elected to undergo RFA.F I G U R E 1 (A) Pre-radiofrequency ablation (RFA) sonography revealed a 3.20 Â 2.62 Â 3.63 cm left thyroid nodule.(B) Free T4, TSH, and thyroglobulin (Tg) levels over time with reference values in lighter-colored blocks.(C) Thyroid nodule size, vascularity, and volume reduction rate (VRR) were demonstrated.*Vascularity, "+" for peripheral, "++" for central vascularity under 50% of the volume.(D) Post-RFA sonography at 46 weeks revealed the nodule measuring 2.19 Â 1.82 Â 2.45 cm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Department of Otorhinolaryngology-Head and Neck Surgery, International Thyroid Surgery Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Department of Otorhinolaryngology, School of Post-Baccalaureate Medicine and School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
ORCID-Profile: How-Chen Wang, Che-Wei Wu, Tzu-Yen Huang
Förderung
- Kaohsiung Medical University Hospital, Kaohsiung Medical University
- National Science and Technology Council, Taiwan
- Kaohsiung Medical University Hospital
Zitieren
APA
Wang, H. C., Wu, C. W., & Huang, T. Y. (2024). Hyperthyroidism after radiofrequency ablation for thyroid nodule. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.12809
Vancouver
Wang HC, Wu CW, Huang TY. Hyperthyroidism after radiofrequency ablation for thyroid nodule. The Kaohsiung Journal of Medical Sciences. 2024. doi:10.1002/kjm2.12809
BibTeX
@article{Wang2024,
author = {Wang, How-Chen and Wu, Che-Wei and Huang, Tzu-Yen},
title = {Hyperthyroidism after radiofrequency ablation for thyroid nodule},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2024},
doi = {10.1002/kjm2.12809}
}
EUVIMED